BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 32788238)

  • 1. IL-6 regulates CCR5 expression and immunosuppressive capacity of MDSC in murine melanoma.
    Weber R; Riester Z; Hüser L; Sticht C; Siebenmorgen A; Groth C; Hu X; Altevogt P; Utikal JS; Umansky V
    J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32788238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCR5 in recruitment and activation of myeloid-derived suppressor cells in melanoma.
    Umansky V; Blattner C; Gebhardt C; Utikal J
    Cancer Immunol Immunother; 2017 Aug; 66(8):1015-1023. PubMed ID: 28382399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCR5
    Blattner C; Fleming V; Weber R; Himmelhan B; Altevogt P; Gebhardt C; Schulze TJ; Razon H; Hawila E; Wildbaum G; Utikal J; Karin N; Umansky V
    Cancer Res; 2018 Jan; 78(1):157-167. PubMed ID: 29089297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STAT3 inhibitor Napabucasin abrogates MDSC immunosuppressive capacity and prolongs survival of melanoma-bearing mice.
    Bitsch R; Kurzay A; Özbay Kurt F; De La Torre C; Lasser S; Lepper A; Siebenmorgen A; Müller V; Altevogt P; Utikal J; Umansky V
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35301236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth.
    Schlecker E; Stojanovic A; Eisen C; Quack C; Falk CS; Umansky V; Cerwenka A
    J Immunol; 2012 Dec; 189(12):5602-11. PubMed ID: 23152559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCR5 Blockade Suppresses Melanoma Development Through Inhibition of IL-6-Stat3 Pathway via Upregulation of SOCS3.
    Tang Q; Jiang J; Liu J
    Inflammation; 2015 Dec; 38(6):2049-56. PubMed ID: 26047948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model.
    Meyer C; Sevko A; Ramacher M; Bazhin AV; Falk CS; Osen W; Borrello I; Kato M; Schadendorf D; Baniyash M; Umansky V
    Proc Natl Acad Sci U S A; 2011 Oct; 108(41):17111-6. PubMed ID: 21969559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of CCR5-mediated myeloid derived suppressor cell accumulation enhances anti-PD1 efficacy in gastric cancer.
    Yang L; Wang B; Qin J; Zhou H; Majumdar APN; Peng F
    Immunopharmacol Immunotoxicol; 2018 Feb; 40(1):91-97. PubMed ID: 29303012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking Migration of Polymorphonuclear Myeloid-Derived Suppressor Cells Inhibits Mouse Melanoma Progression.
    Groth C; Arpinati L; Shaul ME; Winkler N; Diester K; Gengenbacher N; Weber R; Arkhypov I; Lasser S; Petrova V; Augustin HG; Altevogt P; Utikal J; Fridlender ZG; Umansky V
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33578808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive activity is attenuated by Astragalus polysaccharides through remodeling the gut microenvironment in melanoma mice.
    Ding G; Gong Q; Ma J; Liu X; Wang Y; Cheng X
    Cancer Sci; 2021 Oct; 112(10):4050-4063. PubMed ID: 34289209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor NLRP3-Derived IL-1β Drives the IL-6/STAT3 Axis Resulting in Sustained MDSC-Mediated Immunosuppression.
    Tengesdal IW; Dinarello A; Powers NE; Burchill MA; Joosten LAB; Marchetti C; Dinarello CA
    Front Immunol; 2021; 12():661323. PubMed ID: 34531850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Development and Homing of Myeloid-Derived Suppressor Cells: From a Two-Stage Model to a Multistep Narrative.
    Karin N
    Front Immunol; 2020; 11():557586. PubMed ID: 33193327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCR5/CCR5 ligand-induced myeloid-derived suppressor cells are related to the progression of endometriosis.
    Guo P; Bi K; Lu Z; Wang K; Xu Y; Wu H; Cao Y; Jiang H
    Reprod Biomed Online; 2019 Oct; 39(4):704-711. PubMed ID: 31427176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid-Derived Suppressor Cells Are a Major Source of Wnt5A in the Melanoma Microenvironment and Depend on Wnt5A for Full Suppressive Activity.
    Douglass SM; Fane ME; Sanseviero E; Ecker BL; Kugel CH; Behera R; Kumar V; Tcyganov EN; Yin X; Liu Q; Chhabra Y; Alicea GM; Kuruvilla R; Gabrilovich DI; Weeraratna AT
    Cancer Res; 2021 Feb; 81(3):658-670. PubMed ID: 33262126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic DNA vaccine targeting Foxp3
    Namdar A; Mirzaei R; Memarnejadian A; Boghosian R; Samadi M; Mirzaei HR; Farajifard H; Zavar M; Azadmanesh K; Elahi S; Noorbakhsh F; Rezaei A; Hadjati J
    Cancer Immunol Immunother; 2018 Mar; 67(3):367-379. PubMed ID: 29124314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visualization and quantification of
    Hoffmann SHL; Reck DI; Maurer A; Fehrenbacher B; Sceneay JE; Poxleitner M; Öz HH; Ehrlichmann W; Reischl G; Fuchs K; Schaller M; Hartl D; Kneilling M; Möller A; Pichler BJ; Griessinger CM
    Theranostics; 2019; 9(20):5869-5885. PubMed ID: 31534525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanoma Extracellular Vesicles Generate Immunosuppressive Myeloid Cells by Upregulating PD-L1 via TLR4 Signaling.
    Fleming V; Hu X; Weller C; Weber R; Groth C; Riester Z; Hüser L; Sun Q; Nagibin V; Kirschning C; Bronte V; Utikal J; Altevogt P; Umansky V
    Cancer Res; 2019 Sep; 79(18):4715-4728. PubMed ID: 31337655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mTOR signal regulates myeloid-derived suppressor cells differentiation and immunosuppressive function in acute kidney injury.
    Zhang C; Wang S; Li J; Zhang W; Zheng L; Yang C; Zhu T; Rong R
    Cell Death Dis; 2017 Mar; 8(3):e2695. PubMed ID: 28333137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCR1 and CCR5 mediate cancer-induced myelopoiesis and differentiation of myeloid cells in the tumor.
    Zilio S; Bicciato S; Weed D; Serafini P
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35064009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor release.
    Jayaraman P; Parikh F; Lopez-Rivera E; Hailemichael Y; Clark A; Ma G; Cannan D; Ramacher M; Kato M; Overwijk WW; Chen SH; Umansky VY; Sikora AG
    J Immunol; 2012 Jun; 188(11):5365-76. PubMed ID: 22529296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.